lexiara

Article 50

Council Regulation (EEC) No 2309/93 of 22 July 1993 laying down Community procedures for the authorization and supervision of medicinal products for human and veterinary use and establishing a European Agency for the Evaluation of Medicinal Products · European Union

1. The Agency shall comprise: the Committee for Proprietary Medicinal Products, which shall be responsible for preparing the opinion of the Agency on any question relating to the evaluation of medicinal products for human use; the Committee for Veterinary Medicinal Products, which shall be responsible for preparing the opinion of the Agency on any question relating to the evaluation of veterinary medicinal products; a Secretariat, which shall provide technical and administrative support for the two Committees and ensure appropriate coordination between them; an Executive Director, who shall exercise the responsibilities set out in Article 55; a Management Board, which shall exercise the responsibilities set out in Articles 56 and 57. 2. The Committee for Proprietary Medicinal Products and the Committee for Veterinary Medicinal Products may each establish working parties and expert groups. 3. The Committee for Proprietary Medicinal Products and the Committee for Veterinary Medicinal Products may, if they consider it appropriate, seek guidance on important questions of a general scientific or ethical nature.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.